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Spread of multidrug-resistant tuberculosis (MDR-TB) strains in the general population presents a serious
threat to public health and severely threatens existing control efforts. Techniques such as spoligotyping
and Mycobacterium interspersed repetitive unitsdvariable-number tandem-repeat typing of mycobac-
terial isolates have been employed to conﬁrm familial outbreaks of MDR-TB. We diagnosed and traced
four MDR-TB cases in a family via genotyping. Despite aggressive treatment, the index case remained
culture positive, but the other patients were cured. This is the ﬁrst documentation of a familial MDR-TB
outbreak affecting human immunodeﬁciency virus-seronegative patients in eastern Taiwan. Molecular
techniques are important in the identiﬁcation of sources of MDR-TB infections. The adult index case in
our study developed MDR-TB due to poor compliance with the drug regimen (acquired resistance),
followed by transmission of MDR-TB to his children in close household contact. This emphasizes the
importance of an effective drug delivery program, such as directly observed treatment, to improve drug
compliance and prevent the emergence of drug-resistant cases.
Copyright © 2014, Buddhist Compassion Relief Tzu Chi Foundation. Published by Elsevier Taiwan LLC.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).1. Introduction
The World Health Organization estimated that the incidence of
multidrug-resistant tuberculosis (MDR-TB), deﬁned as isolates with
resistance to at least isoniazid and rifampicin, was
220,000e400,000 cases (best estimate, 310,000) in the year 2011.
MDR-TB has become an important issue in the management of TB
[1]. The spread ofMDR-TB strains in the general populationpresents
a serious threat to public health and severely threatens existing
control efforts, because the treatment of MDR-TB is prolonged
(18e24months), less efﬁcacious (success rate<60%),more toxic, and
much costlier [2] than that of drug-susceptible tuberculosis.
MDR-TB can result from new transmission of a resistant strain
(primary transmission) or poor management of a patient infected
with drug-susceptible organisms (acquired resistance). OutbreaksMedicine, Buddhist Tzu Chi
ualien, Taiwan. Tel.: þ886 3
lief Tzu Chi Foundation. Publishedof MDR-TB have occurred in health care facilities and institutional
settings, primarily involving patients infected with the human
immunodeﬁciency virus (HIV) [3e5]. A combination of epidemio-
logic investigation and genotyping has been used to ﬁnd the origin
of outbreaks and track dissemination of MDR-TB strains. In this
report, we describe four HIV-seronegative MDR-TB cases in an
aboriginal family in eastern Taiwan.
2. Case Reports
2.1. Case 1
The index case (Case 1) was an aboriginal manwhowas a tunnel
worker. He lived in the village of Wan-Rong, Taiwanwhich had a TB
incidence of 512.5 cases per population of 100,000 in 2006. He was
ﬁrst diagnosed with pulmonary TB in November 2000, when he
was 43 years old. Sputum smears were positive for acid-fast bacilli,
and sputum cultures grew Mycobacterium tuberculosis. This isolate
was sensitive to all ﬁrst-line drugs. The patient was cured after 8
months of standardized treatment, but due to a relapse in February
2002, antituberculosis treatment was restarted.by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
T.Q. Tang et al. / Tzu Chi Medical Journal 28 (2016) 29e3230During the second treatment course, the patient showed poor
compliance with the treatment regimen. Sputum cultures were
again positive in April 2004, and chest radiography revealed
worsening of left lung inﬁltrations and cavitations (Fig. 1A). The
results of a drug-susceptibility test (DST) of the sputum culture 2
months later revealed resistance to isoniazid (H) and rifampicin (R),
so the patient's regimen was changed to ethambutol (E), pyr-
azinamide (Z), streptomycin (S), prothionamide (Pto), and moxi-
ﬂoxacin (Mfx). In September 2005, sputum cultures still grew
M. tuberculosis, and repeated DST showed resistance to HERS.
The patient was enrolled in a directly observed therapy program
(DOT-plus) in 2007, and continued treatment with E, Z, Pto, Mfx,
para-aminosalicylic acid, and rifabutin (Rfb). However, this sputum
cultures remained positive. Despite the use of Group IeV antitu-
berculosis drugs, the patient's sputum cultures remained positive
at the time of this report. He was diagnosed to have chronic MDR-
TB in 2009 and was placed in long-term isolation in a negative-
pressure room.
2.2. Case 2
Case 2 is the third daughter of the index case. In 2002, she was
diagnosed with pulmonary TB at the age of 19 years. At that time,
the isolated strain was sensitive to HERS. She completed 8 monthsFig. 1. Chest radiographs of four patients with multidrug-resistantof treatment with HERZ and was cured in June 2003. However, in
November 2006, a follow-up chest radiograph (Fig. 1B) and sputum
cultures conﬁrmed recurrent disease. DST showed resistance to HR,
so she was treated with E, Z, S, Pto, andMfx. Streptomycinwas used
for 6 months, and she completed an 18-month treatment course
and was cured in September 2008.
2.3. Case 3
Case 3 is the index patient's older son. He was diagnosed with
pulmonary TB in May 2005, at the age of 14 years, during a regular
health checkup. A chest radiograph revealed inﬁltrations in the left
upper lobe (Fig. 1C). He was treated with HERZS, but 2 months later
DST showed HER resistance. The regimenwas switched to Z, S, Pto,
Rfb, and Mfx. Streptomycin was used for 7 months. He completed
18 months of treatment and was cured in January 2007.
2.4. Case 4
Case 4 is the index patient's younger son. He was ﬁrst diagnosed
in November 2006, at the age of 13 years. A chest radiograph
revealed inﬁltrations and cavitations over the left upper lobe
(Fig. 1D). The ﬁrstM. tuberculosis isolate was fully drug susceptible,
and he was treated with HERZ. However, due to persistent positivetuberculosis: (A) Case 1, (B) Case 2, (C) Case 3, and (D) Case 4.
Fig. 2. Pedigree of MDR-TB family. MDR-TB ¼ multidrug-resistant tuberculosis.
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T.Q. Tang et al. / Tzu Chi Medical Journal 28 (2016) 29e32 31sputum cultures 3 months after starting treatment, DST was
repeated and revealed resistance to HERS. The regimen was
switched to Z, kanamycin, para-aminosalicylic acid, Pto, Rfb, and
Mfx. He was cured in March 2009 after sputum conversion for 18
months. All four patients were tested for antibodies to HIV by
enzyme immunoassay, and all were found to be negative (Fig. 2).
Drug susceptibility testing was performed by the indirect
proportion method. M. tuberculosis isolated from all four patients
revealed similar multiple drug resistance to ﬁrst-line HER and
second-line oﬂoxacin. Fortunately, the strains were sensitive to
kanamycin (Table 1). Isolates of MDR-TB stains from the four pa-
tients showed identical genotypes indistinguishable from each
other by spoligotyping andMycobacterium interspersed repetitive
unitsdvariable-number tandem-repeat (MIRU-VNTR) typing
(Table 2).ti
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t.3. Discussion
The household transmission in this family was proved by
identical spoligotyping and MIRU-VNTR typing. The MDR-TB
outbreak outlined in this study shows the potential of molec-
ular epidemiology and ﬁeld epidemiology in illustrating the
sequence of transmission in clusters of MDR-TB. In the early
1950s, investigators reported that isoniazid-resistant strains of
M. tuberculosis lacked catalase activity and were less virulent in
guinea pigs and mice [6e10] than susceptible strains. It was
hypothesized that drug-resistant strains of M. tuberculosis
might be less capable of being transmitted and less likely to
produce secondary cases compared with drug-susceptible
strains [9]. However, observations by Snider et al [10] sug-
gested that the population in contact with MDR-TB bacilli
developed the disease at the same rate as those in contact with
drug-susceptible bacilli. More recently in Brazil, Teixeira et al
[11] found that transmission and development of TB were
comparable between household contacts with MDR-TB and
those with drug-susceptible TB. In South Africa, Schaaf et al [12]Table 1
DST of strains of four patients.
Case Date H Rif E Sm Km Pto PAS Ofx Cm Rifabutin
1 Nov 25, 2006 R R R R S S S R S R
2 Nov 17, 2006 R R R S S R S R S R
3 Nov 17, 2006 R R R S S S S R S R
4 May 17, 2006 R R R R S S S R S R
Cm¼ capreomycin; DST¼ drug-susceptibility test; E¼ ethambutol; H¼ isoniazid;
Km ¼ kanamycin; Ofx ¼ oﬂoxacin; Pto ¼ prothionamide; R ¼ resistant; R ¼ Rif;
S ¼ susceptible; Sm ¼ streptomycin. Ta
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T.Q. Tang et al. / Tzu Chi Medical Journal 28 (2016) 29e3232examined the prevalence of PPD reactivity and active TB in
children, and concluded that the incidence of infection and
disease in children in contact with MDR-TB adult index cases was
comparable with that occurring in children in contact with drug-
susceptible adult index cases. Our report conﬁrmed the house-
hold transmission of MDR-TB infection from an adult index case
to his three children.
The MDR-TB genotypes from all four patients belonged to the
Beijing family. Beijing family genotypes ofM. tuberculosiswere ﬁrst
recognized in 1995. This family of strains accounted for 86% of
tuberculosis isolates collected from Beijing, China [13], and it has
spread worldwide. In 2005, Jou et al [14] reported that 187 of 421
M. tuberculosis isolates (44.4%) collected randomly in four
geographic regions of Taiwan belonged to Beijing family genotypes.
Antituberculosis drug resistance has been found more often in
Beijing family genotype strains (46.4%) than in non-Beijing family
genotype strains (34.4%). A countrywide study in Estonia also
showed a strong correlation between the Beijing family and drug
resistance. The Beijing family accounted for 87.5% of all MDR-TB
isolates and 67.2% of all isolates with any drug resistance [15].
Some strains of the Beijing family have been demonstrated to
have high virulence and were associated with active transmission
young people who had BCG immunizations in Vietnam [16]. The
adult index case in our study developed MDR-TB due to poor
compliance with the drug regimen (acquired resistance), followed
by transmission of MDR-TB to his children in close household
contact (primary transmission). This emphasizes the importance of
an effective drug delivery program such as DOT to improve drug
compliance and prevent the emergence of drug-resistant cases. In
addition, the prolonged infectious period of the index case
increased the risk of household transmission. Timely diagnosis of
MDR-TB and effective patient-centered treatment would help
prevent transmission of MDR-TB in families and communities.
In recent years, several ﬁngerprinting methods for typing
mycobacteria isolates have become available. The most widely used
molecular methods forM. tuberculosis isolates are IS6110 restriction
fragment length polymorphism (RFLP) typing, spoligotyping, and
MIRU-VNTR typing. IS6110 RFLP typing of M. tuberculosis has been
the gold standard for genotyping. However, it is laborious, time
consuming, and expensive.
The optimized MIRU-VNTR set combined with spoligotyping
showed a slightly higher predictive value for the study of TB
transmission than the current gold standard IS6110 RFLP [17].
Spoligotyping combined with MIRU-VNTR is less labor intensive
than IS6110 RFLP. Because of its rapidity and ease of data exchange
and comparison, this method has the potential to replace RFLP as
the gold standard, and can help facilitate research and international
comparisons in the molecular epidemiology of TB.
Early detection and appropriate treatment of MDR-TB can result
in a favorable response. Although the three children of the index
case were infected with the same MDR-TB strain, their cases weredetected early and they were compliant with treatment with
second-line medications. Noncompliance of the index case resulted
in the occurrence of MDR-TB, and he failed to showconversion even
after years of treatment with second-line drugs. He is now under
forced isolation for the rest of his life in a negative pressure setting.
This serves as a solemn reminder of the importance of early
detection and medical compliance.
In summary, to our knowledge, this is the ﬁrst documentation of
a familial MDR-TB outbreak affecting HIV-seronegative patients in
eastern Taiwan.References
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